URI-affiliated biotech raises $12M to advance Alzheimer’s treatment


MindImmune says its antibody treatment could prevent immune cells from entering the brain and damaging neurons.

Previous Bluebird stock soars on FDA committee news, despite overall market woes
Next 20 People to Know in Health Care: Jeanne Iasella, chief solutions officer, TeleTracking Technologies Inc.